Susquehanna International Group, LLP Aerie Pharmaceuticals Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $94,766 - $226,576	14,877 New	14,877 $225,000
Q1 2022 May 16, 2022	SELL	$5.64 - $9.8 $97,831 - $169,990	-17,346 Reduced 60.9%	11,137 $101,000
Q3 2021 Nov 15, 2021	BUY	$11.32 - $16.63 $322,427 - $473,672	28,483 New	28,483 $325,000
Q2 2021 Aug 11, 2021	SELL	$15.16 - $18.97 $184,375 - $230,713	-12,162 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$13.12 - $20.9 $153,228 - $244,091	-11,679 Reduced 48.99%	12,162 $217,000
Q4 2020 Feb 16, 2021	SELL	$9.12 - $14.49 $260,458 - $413,819	-28,559 Reduced 54.5%	23,841 $322,000
Q3 2020 Nov 16, 2020	BUY	$10.46 - $14.46 $281,520 - $389,176	26,914 Added 105.6%	52,400 $617,000
Q2 2020 Aug 14, 2020	SELL	$12.0 - $16.13 $748,092 - $1.01 Million	-62,341 Reduced 70.98%	25,486 $376,000
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $384,657 - $829,093	-32,488 Reduced 27.0%	87,827 $1.19 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $94,627 - $143,920	5,140 Added 4.46%	120,315 $2.31 Million
Q2 2019 Aug 16, 2019	BUY	$28.97 - $48.21 $78,363 - $130,408	2,705 Added 2.41%	115,175 $3.4 Million
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $2.84 Million - $4.73 Million	98,060 Added 680.5%	112,470 $3.32 Million
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $133,155 - $242,261	-4,035 Reduced 21.88%	14,410 $520,000
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $485,697 - $639,235	8,650 Added 88.31%	18,445 $1.14 Million
Q2 2018 Aug 14, 2018	SELL	$47.85 - $70.45 $8.09 Million - $11.9 Million	-169,162 Reduced 94.53%	9,795 $662,000
Q4 2017 Feb 14, 2018	BUY	$50.85 - $65.1 $6.22 Million - $7.97 Million	122,357 Added 216.18%	178,957 $10.7 Million
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $2.75 Million - $3.4 Million	56,600	56,600 $2.75 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account